![Po Wen Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Po Wen Wu
Director Ejecutivo en
Polaris Pharmaceuticals, Inc.
.
Perfil
Po Wen Wu is currently the President & Chief Executive Officer at Polaris Pharmaceuticals, Inc. and the Chairman & Chief Executive Officer at Designerx Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at DRX USA, DRX Chengdu, and TDW Pharmaceuticals, Inc. Additionally, he serves as a Director at DesigneRx Europe Ltd., DRX SHANGHAI, and DRX Hong Kong.
In the past, he was the President & Chief Executive Officer at Polaris Group, Inc. from 2011 to 2013 and the Chairman & General Manager at Polaris Group.
Dr. Wu holds a doctorate degree from the University of California, Berkeley.
Cargos activos de Po Wen Wu
| Empresas | Cargo | Inicio |
|---|---|---|
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Researches and develops protein drugs for cancer treatment | Director Ejecutivo | - |
DesigneRx Europe Ltd. | Director/Miembro de la Junta | - |
Designerx Pharmaceuticals, Inc.
 Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu. | Director Ejecutivo | - |
DRX USA | Director Ejecutivo | - |
TDW Pharmaceuticals, Inc. | Director Ejecutivo | - |
DRX Chengdu | Director Ejecutivo | - |
DRX SHANGHAI | Director/Miembro de la Junta | - |
DRX Hong Kong | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Po Wen Wu.
| Empresas | Cargo | Fin |
|---|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Offers real estate sales, marketing & consulting services | Presidente | 06/03/2013 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Formación de Po Wen Wu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
12
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaris Group, Inc.
Polaris Group, Inc. Real Estate DevelopmentFinance Offers real estate sales, marketing & consulting services | Finance |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Researches and develops protein drugs for cancer treatment | Health Technology |
TDW Pharmaceuticals, Inc. | |
Polaris Group
 Polaris Group BiotechnologyHealth Technology Engages in research and development of protein drugs to treat cancer and other debilitating diseases in humans | Health Technology |
DesigneRx Europe Ltd. | |
Designerx Pharmaceuticals, Inc.
Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu. | Health Technology |
DRX USA | |
DRX Chengdu | |
DRX SHANGHAI | |
DRX Hong Kong |
- Bolsa de valores
- Insiders
- Po Wen Wu
Elige MarketScreener 
